On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo.

Palo Santo is a leading therapeutics investment fund dedicated to increasing the global supply of clinically effective and accessible healthcare solutions.

Tim is a Co-Founder and Partner of the fund, sits on the Board of many psychedelics companies, and recently closed a $50 million fund.

Tune in to learn more about Palo Santo’s investment thesis, portfolio, and goals for the future of psychedelic-assisted therapies and beyond.

Only One More Episode Remains for Season Two

There is only one episode left in season two and we promise we’ll be closing it out with a bang. Don’t miss out on it next Wednesday.

This podcast is available on Apple Podcasts, Spotify, Google Podcasts, and everywhere podcasts can be found.

The Transcription is Coming Soon